White Papers
-
AI in Pharma: Benefits, Risks, And The Road Ahead
10/23/2024
How could leveraging AI technologies, including machine learning (ML) and generative AI (GenAI), enable your company to streamline processes from drug discovery to post-launch?
-
A Promising Rebound in Clinical Trials
10/23/2024
This report explores how clinical trials bounced back in 2023 from their decline a year earlier despite continued geopolitical, regulatory, and pricing pressures.
-
The Importance Of A Maturity Model For Clinical Trial Transparency
10/23/2024
A comprehensive maturity model for clinical trial disclosure and transparency offers companies a strategic tool to assess and enhance their practices in an increasingly complex regulatory environment.
-
Real-World Value Realized From DHTs In Clinical Trials
10/22/2024
Explore four real-world examples of clinical trials that successfully integrated DHTs. Each case study highlights how DHTs impacted specific aspects of trial design.
-
Bispecific Antibody PK And ADA Bioanalysis: An Experienced Approach
10/16/2024
This article outlines a strategic approach to address these bioanalytical challenges for BsAbs, ensuring accurate and reliable assessment of safety and efficacy.
-
Cervical Cancer - Global Clinical Trial Landscape (2024)
10/15/2024
Expand your understanding of the cervical cancer (CC) clinical trial landscape, including current drug development funding, and the effect of this disease on the world.
-
Diffuse Large B-Cell Lymphoma- Global Clinical Trial Landscape
10/15/2024
Explore the latest advancements in diffuse large B-cell lymphoma research, innovative therapies, and personalized care strategies shaping the future of treatment.
-
New Duke Research Shows Participants Prefer Enhanced eConsent
10/7/2024
It’s apparent to those who have used it that the “e” in eConsent could stand for much more than 'electronic'. Duke’s new research shows why participants prefer an eConsent experience bolstered with videos, media, questions, and more.
-
Harnessing FSP Engagements To Deliver On-Time, On-Budget
10/4/2024
The strategic use of FSPs helps biotech companies minimize risks, maintain compliance, and accelerate the development of life-changing therapies, illustrating the importance of industry outsourcing partnerships.
-
Digital Innovation In Pharmacovigilance
10/1/2024
Explore how AI can transform your pharmacovigilance efforts and enhance patient safety by leveraging the insights and decision framework outlined here.